Allianz Asset Management’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.39M | Sell |
14,600
-28,007
| -66% | -$4.31M | ﹤0.01% | 1492 |
|
|
2025
Q4 | $7.42M | Sell |
42,607
-23,476
| -36% | -$4.28M | 0.01% | 962 |
|
|
2025
Q3 | $9.52M | Sell |
66,083
-14,339
| -18% | -$1.76M | 0.01% | 862 |
|
|
2025
Q2 | $8.09M | Buy |
80,422
+5,138
| +7% | +$393K | 0.01% | 892 |
|
|
2025
Q1 | $5.74M | Buy |
75,284
+3,534
| +5% | +$270K | 0.01% | 1035 |
|
|
2024
Q4 | $4.95M | Sell |
71,750
-33,927
| -32% | -$2.44M | 0.01% | 1052 |
|
|
2024
Q3 | $7.71M | Sell |
105,677
-9,500
| -8% | -$701K | 0.01% | 842 |
|
|
2024
Q2 | $7.72M | Buy |
115,177
+24,500
| +27% | +$950K | 0.01% | 787 |
|
|
2024
Q1 | $2.46M | Buy |
90,677
+61,677
| +213% | +$1.73M | ﹤0.01% | 1116 |
|
|
2023
Q4 | $899K | Buy |
29,000
+6,600
| +29% | +$171K | ﹤0.01% | 1640 |
|
|
2023
Q3 | $566K | Sell |
22,400
-3,900
| -15% | -$89.2K | ﹤0.01% | 1881 |
|
|
2023
Q2 | $555K | Hold |
26,300
| – | – | ﹤0.01% | 1708 |
|
|
2023
Q1 | $448K | Hold |
26,300
| – | – | ﹤0.01% | 1918 |
|
|
2022
Q4 | $525K | Sell |
26,300
-12,700
| -33% | -$245K | ﹤0.01% | 1717 |
|
|
2022
Q3 | $840K | Sell |
39,000
-266,635
| -87% | -$6.39M | ﹤0.01% | 1446 |
|
|
2022
Q2 | $6.03M | Buy |
305,635
+151,859
| +99% | +$3.18M | 0.01% | 1045 |
|
|
2022
Q1 | $3.61M | Buy |
153,776
+44,841
| +41% | +$1.04M | ﹤0.01% | 1348 |
|
|
2021
Q4 | $2.97M | Buy |
108,935
+7,855
| +8% | +$225K | ﹤0.01% | 1457 |
|
|
2021
Q3 | $2.78M | Buy |
101,080
+68,940
| +214% | +$1.81M | ﹤0.01% | 1513 |
|
|
2021
Q2 | $914K | Buy |
32,140
+9,445
| +42% | +$280K | ﹤0.01% | 1777 |
|
|
2021
Q1 | $773K | Hold |
22,695
| – | – | ﹤0.01% | 1743 |
|
|
2020
Q4 | $755K | Hold |
22,695
| – | – | ﹤0.01% | 1549 |
|
|
2020
Q3 | $730K | Sell |
22,695
-7,983
| -26% | -$229K | ﹤0.01% | 1516 |
|
|
2020
Q2 | $845K | Sell |
30,678
-21,251
| -41% | -$504K | ﹤0.01% | 1874 |
|
|
2020
Q1 | $833K | Sell |
51,929
-7,584
| -13% | -$180K | ﹤0.01% | 1864 |
|
|
2019
Q4 | $1.42M | Sell |
59,513
-118,532
| -67% | -$2.41M | ﹤0.01% | 2037 |
|
|
2019
Q3 | $3.17M | Sell |
178,045
-31,595
| -15% | -$610K | ﹤0.01% | 1640 |
|
|
2019
Q2 | $5.37M | Sell |
209,640
-59,279
| -22% | -$1.65M | 0.01% | 1466 |
|
|
2019
Q1 | $7.82M | Buy |
268,919
+126,001
| +88% | +$3.27M | 0.01% | 1248 |
|
|
2018
Q4 | $1.87M | Sell |
142,918
-38,477
| -21% | -$614K | ﹤0.01% | 1793 |
|
|
2018
Q3 | $3.67M | Buy |
181,395
+102,745
| +131% | +$2.32M | ﹤0.01% | 1695 |
|
|
2018
Q2 | $1.86M | Buy |
+78,650
| New | +$2.02M | ﹤0.01% | 1976 |
|
|
2015
Q4 | – | Sell |
-74,426
| Closed | -$1.38M | – | 2474 |
|
|
2015
Q3 | $1.38M | Buy |
74,426
+1,389
| +2% | +$34.7K | ﹤0.01% | 1713 |
|
|
2015
Q2 | $1.78M | Sell |
73,037
-78
| -0.1% | -$1.77K | ﹤0.01% | 1748 |
|
|
2015
Q1 | $1.52M | Sell |
73,115
-13,882
| -16% | -$245K | ﹤0.01% | 1641 |
|
|
2014
Q4 | $1.35M | Sell |
86,997
-688
| -0.8% | -$9.76K | ﹤0.01% | 1717 |
|
|
2014
Q3 | $1.14M | Sell |
87,685
-4,359
| -5% | -$65.7K | ﹤0.01% | 1624 |
|
|
2014
Q2 | $1.84M | Buy |
92,044
+7,839
| +9% | +$116K | ﹤0.01% | 1232 |
|
|
2014
Q1 | $1.6M | Sell |
84,205
-5,109
| -6% | -$97.1K | ﹤0.01% | 1281 |
|
|
2013
Q4 | $1.52M | Sell |
89,314
-5,176
| -5% | -$79.3K | ﹤0.01% | 1287 |
|
|
2013
Q3 | $1.48M | Buy |
+94,490
| New | +$1.2M | ﹤0.01% | 1281 |
|
Other funds holding INSM
DGM
VPM
VCM
BBA
Allianz Asset Management's INSM Position: Q1 2026 in Review
Allianz Asset Management reduced its Insmed (INSM) stake by 66% in Q1 2026, selling an estimated $4.31M and leaving 14,600 shares worth $2.39M. The position accounts for ﹤0.01% of the portfolio, ranked #1492.
Allianz Asset Management first reported a position in INSM in Q3 2013 and has held it in 41 quarters since. The position peaked at $9.52M in Q3 2025. 670 funds tracked by Wall St. Rank hold INSM as of Q1 2026.
- Allianz Asset Management held 14,600 shares of Insmed worth $2.39M as of Q1 2026.
- Allianz Asset Management sold 28,007 Insmed shares in Q1 2026, an estimated $4.31M.
- Insmed made up ﹤0.01% of Allianz Asset Management's portfolio in Q1 2026, its #1492 holding.
- Allianz Asset Management first reported a position in Insmed in Q3 2013 and has held it in 41 quarters since.
- Allianz Asset Management's Insmed position peaked at $9.52M in Q3 2025.
- 670 funds tracked by Wall St. Rank held Insmed as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.